<DOC>
	<DOCNO>NCT01086501</DOCNO>
	<brief_summary>The aim observational study investigate safety oxcarbazepine extend release ( ER ) long-term therapy epileptic patient . In addition , quality life parameter document assessed .</brief_summary>
	<brief_title>ESOXC-ER Efficacy Safety Extended Release ( ER ) Formulation Oxcarbazepine ( Apydan Extent ) Epileptic Patients</brief_title>
	<detailed_description />
	<mesh_term>Oxcarbazepine</mesh_term>
	<criteria>patient focal epileptic seizure without secondary generalise tonicclonic seizure mono combination therapy male female age 6 hypersensitivity oxcarbazepine MR one excipients</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>open , non-interventional</keyword>
</DOC>